AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2590619 — intervention group
Group type: EXPERIMENTAL
Intervention: Psorin (low concentration dithranol and coal tar)
Number of subjects: 23
Study 2590619 — intervention group
Group type: COMPARATOR
Intervention: Alphosyl (alcoholic coal tar extract and allantoin)
Number of subjects: 23
Study 1020902 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 000 units of heparin preoperatively and every 12 hours following the operation
Number of subjects: 10
Study 1020902 — intervention group
Group type: COMPARATOR
Intervention: Saline at the corresponding time
Number of subjects: 10
Study 31630117 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed treatment group (3 mg/kg IFX until week 6, then dose adjusted based on baseline TNF-α levels until week 54)
Number of subjects: 337
Study 31630117 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (3 mg/kg IFX)
Number of subjects: 337
Study 31630117 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed treatment group
Number of subjects: 337
Study 31630117 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 337
Study 31630117 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 337
Study 31744523 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly built birthing room designed with a person‐centred approach and physical aspects (light, silencer, media installation, bathtub, birth support tools)
Number of subjects: 1274
Study 31744523 — intervention group
Group type: COMPARATOR
Intervention: Regular room (control group)
Number of subjects: 1274
Study 31744523 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly built birthing room
Number of subjects: 1274
Study 27469171 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered interference fit (TIF) implants
Number of subjects: 15
Study 27469171 — intervention group
Group type: COMPARATOR
Intervention: Taper-integrated screwed-in (TIS) implants
Number of subjects: 15
Study 27469171 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TIF and TIS implants
Number of subjects: 15
Study 25582816 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (bilateral BL32 and BL33 acupoints, electrical pulse generator, twice a week for 7 weeks)
Number of subjects: 54
Study 25582816 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (levofloxacin 500 mg daily and ibuprofen 200 mg twice a day for 6 weeks)
Number of subjects: 54
Study 23737921 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized peer-teaching training of practical competences for 45 minutes including surgical scrubbing according to EN1500
Number of subjects: 161
Study 23737921 — intervention group
Group type: COMPARATOR
Intervention: Control group received training after the test
Number of subjects: 161
Study 23737921 — intervention group
Group type: COMPARATOR
Intervention: Clinical reference groups (surgeons)
Number of subjects: 161
Study 23737921 — intervention group
Group type: COMPARATOR
Intervention: Clinical reference groups (scrub nurses)
Number of subjects: 161
Study 21903477 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortivazol 3.75 mg
Number of subjects: 43
Study 21903477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 18930474 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10mg/d for six weeks
Number of subjects: 30
Study 18930474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 16733171 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting (n = 35)
Number of subjects: 70
Study 16733171 — intervention group
Group type: COMPARATOR
Intervention: Conventional coronary artery bypass grafting (n = 35)
Number of subjects: 70
Study 16733171 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological analysis
Number of subjects: 70
Study 16733171 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and left atrial enlargement
Number of subjects: 70
Study 14660503 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral knee extensor resistance exercise (ULRE) performed two or three times weekly.
Number of subjects: 21
Study 14660503 — intervention group
Group type: COMPARATOR
Intervention: Unilateral lower limb unloading (UL) with no training.
Number of subjects: 21
Study 14660503 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral knee extensor resistance exercise (ULRE)
Number of subjects: 21
Study 14660503 — intervention group
Group type: COMPARATOR
Intervention: Unilateral lower limb unloading (UL)
Number of subjects: 21
Study 14660503 — intervention group
Group type: COMPARATOR
Intervention: Unilateral lower limb unloading (UL) and Unilateral knee extensor resistance exercise (ULRE)
Number of subjects: 21
Study 11746863 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol
Number of subjects: 11
Study 11746863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 8996712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) plus buspirone
Number of subjects: 77
Study 8996712 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behaviour therapy (CBT) plus placebo
Number of subjects: 77
Study 8241011 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (15 mg as a bolus intravenously, followed by an infusion of 0.04 mg/kg/hr)
Number of subjects: 27
Study 8241011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 3310369 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (PPA), 50 mg twice daily
Number of subjects: 24
Study 3310369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29359575 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR-Lis
Number of subjects: 27
Study 29359575 — intervention group
Group type: COMPARATOR
Intervention: Ly-Lis
Number of subjects: 27
Study 28342214 — intervention group
Group type: EXPERIMENTAL
Intervention: rtfMRI‐NF of right inferior prefrontal cortex (rIFG)
Number of subjects: 31
Study 28342214 — intervention group
Group type: COMPARATOR
Intervention: rtfMRI‐NF of left parahippocampal gyrus (lPHG)
Number of subjects: 31
Study 23359072 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Living Every Day (ALED) intervention for 20 weeks
Number of subjects: 354
Study 23359072 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 354
Study 23525499 — intervention group
Group type: EXPERIMENTAL
Intervention: rIPC alone in rabbit model
Number of subjects: 24
Study 23525499 — intervention group
Group type: COMPARATOR
Intervention: rIPC after ALDH-2 inhibitor cyanamide in rabbit model
Number of subjects: 24
Study 23525499 — intervention group
Group type: EXPERIMENTAL
Intervention: rIPC in wild-type individuals
Number of subjects: 24
Study 23525499 — intervention group
Group type: EXPERIMENTAL
Intervention: rIPC in carriers of Glu504Lys polymorphism
Number of subjects: 24
Study 23525499 — intervention group
Group type: COMPARATOR
Intervention: rIPC with placebo in double-blind study
Number of subjects: 24
Study 23525499 — intervention group
Group type: EXPERIMENTAL
Intervention: rIPC with disulfiram (600 mg od)
Number of subjects: 24
Study 20888162 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 3006
Study 20888162 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 3006
Study 20888162 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine angiographic follow-up
Number of subjects: 3006
Study 18239561 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (three different intensity treatments)
Number of subjects: 16
Study 18239561 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate (50% VO(2)) and high (75% VO(2)) intensity acute exercise
Number of subjects: 16
Study 18239561 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 16
Study 16328464 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Active Motion (CAM)
Number of subjects: 60
Study 16328464 — intervention group
Group type: COMPARATOR
Intervention: Continuous Passive Motion (CPM)
Number of subjects: 60
Study 12712486 — intervention group
Group type: EXPERIMENTAL
Intervention: aprepitant 125 mg on Day 1 and 80 mg on Days 2-5
Number of subjects: 376
Study 12712486 — intervention group
Group type: EXPERIMENTAL
Intervention: aprepitant 40 mg on Day 1 and 25 mg on Days 2-5
Number of subjects: 376
Study 12712486 — intervention group
Group type: COMPARATOR
Intervention: standard therapy (intravenous ondansetron plus oral dexamethasone)
Number of subjects: 376
Study 10914752 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% dextrose infusion
Number of subjects: 10
Study 10914752 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline infusion
Number of subjects: 10
Study 8819106 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitogen-stimulated lymphocytes from elderly subjects
Number of subjects: 0
Study 8819106 — intervention group
Group type: COMPARATOR
Intervention: Mitogen-stimulated lymphocytes from young individuals
Number of subjects: 0
Study 8158512 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Oral hygiene instructions with scaling and root planing
Number of subjects: 30
Study 8158512 — intervention group
Group type: COMPARATOR
Intervention: Group B: Oral hygiene instructions without subgingival scaling and root planing
Number of subjects: 30
Study 3202452 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg twice a day)
Number of subjects: 7
Study 3202452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 29941911 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 26
Study 29941911 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 26
Study 28692014 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) training
Number of subjects: 23
Study 25280244 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided individualised feedback (written or verbal guidance on interpreting a graphical summary profile)
Number of subjects: 129
Study 22985013 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise for 15 minutes
Number of subjects: 81
Study 22985013 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest (Control)
Number of subjects: 81
Study 21466388 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan added to standard care
Number of subjects: 500000000
Study 21466388 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 500000000
Study 19084786 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion of maternal stress during pediatric primary care visits
Number of subjects: 747
Study 16793562 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin extended-release/lovastatin (500/20 mg) once daily
Number of subjects: 70
Study 16793562 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (20 mg) once daily
Number of subjects: 70
Study 12925473 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg
Number of subjects: 10
Study 12925473 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 10
Study 10929338 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile lavage
Number of subjects: 0
Study 10929338 — intervention group
Group type: COMPARATOR
Intervention: Syringe lavage
Number of subjects: 0
Study 7472905 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intake of 200 IU/day
Number of subjects: 62
Study 7472905 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intake of 400 IU/day
Number of subjects: 62
Study 7472905 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intake of 800 IU/day
Number of subjects: 62
Study 7472905 — intervention group
Group type: COMPARATOR
Intervention: Follow-up after earlier manipulation of vitamin D intake
Number of subjects: 62
Study 2179366 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term continuous subcutaneous infusion of large doses of salbutamol (greater than 14 mg/day)
Number of subjects: 10
Study 2179366 — intervention group
Group type: COMPARATOR
Intervention: Intermittent nebulization of salbutamol
Number of subjects: 10
Study 6986067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 2,000 mg once daily
Number of subjects: 100
Study 6986067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 1,000 mg once daily
Number of subjects: 100
Study 6986067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 1,000 mg twice daily
Number of subjects: 100
Study 30597803 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg L-1 flumequine (FLU)
Number of subjects: 62
Study 30597803 — intervention group
Group type: COMPARATOR
Intervention: Control (absence of FLU)
Number of subjects: 62
Study 28906414 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine jelly applied to the tapered cuff of the endotracheal tube (ETT)
Number of subjects: 208
Study 28906414 — intervention group
Group type: COMPARATOR
Intervention: Normal saline applied to the tapered cuff of the endotracheal tube (ETT)
Number of subjects: 208
Study 26255764 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weekly fractions (fx/w) of radiotherapy
Number of subjects: 694
Study 26255764 — intervention group
Group type: COMPARATOR
Intervention: 5 weekly fractions (fx/w) of radiotherapy
Number of subjects: 694
Study 26255764 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 694
Study 23369174 — intervention group
Group type: EXPERIMENTAL
Intervention: Sites group (treatment)
Number of subjects: 70
Study 23369174 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 21844080 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Electrocardiography (ETT)
Number of subjects: 824
Study 21844080 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Myocardial Perfusion Imaging (MPI)
Number of subjects: 824
Study 19709113 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% (w/v) CPP‐ACP in bovine milk
Number of subjects: 10
Study 19709113 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% (w/v) CPP‐ACP in bovine milk
Number of subjects: 10
Study 19709113 — intervention group
Group type: COMPARATOR
Intervention: Control milk (no added CPP‐ACP)
Number of subjects: 10
Study 18087797 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 16 mg + naloxone 4 mg/day
Number of subjects: 326
Study 18087797 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine 16 mg + placebo
Number of subjects: 326
Study 15533377 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified GnRH antagonist protocol with 75 IU recombinant FSH
Number of subjects: 0
Study 15533377 — intervention group
Group type: COMPARATOR
Intervention: Standard long GnRH agonist protocol
Number of subjects: 0
Study 11552215 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin infusion (1,000,000-KIU loading dose, followed by 250,000-KIU/h infusion during surgery)
Number of subjects: 63
Study 9778719 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol/alfentanil
Number of subjects: 36
Study 9778719 — intervention group
Group type: COMPARATOR
Intervention: midazolam/fentanyl
Number of subjects: 36
Study 7709944 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g elemental calcium)
Number of subjects: 86
Study 7709944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 2691233 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline (500 mg four times daily for a week)
Number of subjects: 140
Study 2691233 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tetracycline)
Number of subjects: 140
Study 4593780 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 14
Study 4593780 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 14
Study 29681188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 64
Study 29681188 — intervention group
Group type: COMPARATOR
Intervention: Myofascial release
Number of subjects: 64
Study 28043731 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (250mg) and Hydrochlorothiazide (50mg) daily
Number of subjects: 20
Study 28043731 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (40mg) and Hydrochlorothiazide (50mg) daily
Number of subjects: 20
Study 24809483 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-task training
Number of subjects: 23
Study 24809483 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-task training
Number of subjects: 23
Study 24809483 — intervention group
Group type: COMPARATOR
Intervention: Novice groups (Part-task and Whole-task)
Number of subjects: 23
Study 23463394 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiodol
Number of subjects: 103
Study 23463394 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 103
Study 22292366 — intervention group
Group type: EXPERIMENTAL
Intervention: Dengzhan group (fleabane injection and Dengzhan Shengmai capsules)
Number of subjects: 678
Study 22292366 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group (WM group)
Number of subjects: 678
Study 19116750 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic group (LG)
Number of subjects: 84
Study 19116750 — intervention group
Group type: COMPARATOR
Intervention: Open group (OG)
Number of subjects: 84
Study 19116750 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 16464386 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinastatin treatment (300 kU for severe burns, 200 kU for moderate burns) administered intravenously twice a day for 5 to 7 days
Number of subjects: 72
Study 16464386 — intervention group
Group type: COMPARATOR
Intervention: Control group received routine therapy
Number of subjects: 72
Study 15471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine group (influenza vaccine composed of A/Texas/36/91 (H1N1), A/Nanchang/933/95 (H3N2), and B/Harbin/07/94 strains)
Number of subjects: 123
Study 15471303 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 123
Study 15471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine group
Number of subjects: 123
Study 15471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without protective HI antibody to A (H1N1)
Number of subjects: 123
Study 15471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without protective HI antibody to A (H3N2)
Number of subjects: 123
Study 15471303 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without protective HI antibody to B
Number of subjects: 123
Study 10692805 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle relaxation training
Number of subjects: 0
Study 9349062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.1 mg.kg‐1 followed by infusion of 3 micrograms.kg‐1.min‐1
Number of subjects: 20
Study 9349062 — intervention group
Group type: COMPARATOR
Intervention: Atracurium 0.5 mg.kg‐1 followed by infusion of 10 micrograms.kg‐1.min‐1
Number of subjects: 20
Study 9349062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 20
Study 9349062 — intervention group
Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 20
Study 7692617 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepacrine
Number of subjects: 40
Study 7692617 — intervention group
Group type: COMPARATOR
Intervention: Bleomycin
Number of subjects: 40
Study 3159552 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.25 percent aluminum chloride in anhydrous alcohol
Number of subjects: 25
Study 3159552 — intervention group
Group type: COMPARATOR
Intervention: Placebo (alcohol alone)
Number of subjects: 25
Study 30236136 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure Small Jaw (LSJ)
Number of subjects: 550
Study 30236136 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 550
Study 27156182 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938
Number of subjects: 101
Study 27156182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 24730528 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS intervention
Number of subjects: 80
Study 24730528 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study 21540760 — intervention group
Group type: COMPARATOR
Intervention: 10-valent pneumococcal nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
Number of subjects: 600
Study 20042092 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber diet (instruction to achieve daily dietary fiber intake of 30 g or more)
Number of subjects: 240
Study 20042092 — intervention group
Group type: COMPARATOR
Intervention: American Heart Association (AHA) diet (instruction to make several dietary changes recommended by AHA 2006 guidelines)
Number of subjects: 240
Study 17459333 — intervention group
Group type: EXPERIMENTAL
Intervention: High-perceived responsibility condition
Number of subjects: 15
Study 17459333 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated checking task
Number of subjects: 15
Study 17459333 — intervention group
Group type: COMPARATOR
Intervention: Student control sample
Number of subjects: 15
Study 16036076 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (rhPTH [1‐34])
Number of subjects: 0
Study 16036076 — intervention group
Group type: COMPARATOR
Intervention: Combination of PTH with other agents (estrogens, calcitonin, bisphosphonates)
Number of subjects: 0
Study 11451272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) therapy for 26 weeks
Number of subjects: 20
Study 11451272 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 20
Study 11451272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) therapy
Number of subjects: 20
Study 9331351 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (0.6 mg/kg)
Number of subjects: 0
Study 9331351 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study 7530680 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral salpingo-oophorectomy with preservation of the contralateral ovary and uterus
Number of subjects: 0
Study 7530680 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with bleomycin, etoposide, and cisplatin
Number of subjects: 0
Study 7530680 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for metastatic dysgerminoma
Number of subjects: 0